MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care
MISTRAL
1 other identifier
interventional
120
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether a structured, Patient-Reported Outcome Measures (PROMs)-tailored palliative care pathway improves clinical outcomes and care experience in adults with advanced cancer referred to outpatient palliative care. Patients with advanced cancer often experience multiple symptoms and complex needs. Standard outpatient palliative care is usually guided by clinical judgment on patient-reported questionnaires. In this study, researchers aim to test whether a more structured approach, based on predefined cut-offs from PROMs, can improve symptom control, satisfaction with care, and use of healthcare resources. The main questions the study aims to answer are: Does a structured, PROM-driven palliative care pathway reduce symptom burden and psychological distress compared with usual care? And through this, to improve patients' and caregivers' satisfaction with care or reduce emergency room visits, hospital admissions, healthcare costs, and aggressive treatments near the end of life? Researchers will compare two groups: Control group: Participants will receive standard outpatient palliative care. PROMs are collected as usual, but without predefined cut-offs or structured intervention checklists. Experimental group: Participants will receive a structured palliative care pathway tailored to symptoms/needs identified at baseline using PROM cut-offs. Specific multidisciplinary interventions are activated according to identified needs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 2, 2025
CompletedFirst Submitted
Initial submission to the registry
March 5, 2026
CompletedFirst Posted
Study publicly available on registry
March 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
March 13, 2026
March 1, 2026
11 months
March 5, 2026
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in overall symptom burden assessed by the ESAS.
\- Mean change in symptom burden from baseline to 1 month after initiation of palliative care, measured using the Edmonton Symptom Assessment System (ESAS) total score (range 0-90, higher scores indicating greater symptom burden). The analysis will compare the change in ESAS total score between the two randomized groups.
1, 3 months
Change in psychological distress assessed by the Distress Thermometer (DT).
Mean change in psychological distress from baseline to 1 month after initiation of palliative care, measured using the Distress Thermometer (DT) (range 0-10, higher scores indicating greater distress). The analysis will compare the change in DT score between the two randomized groups.
1, 3 Months
Secondary Outcomes (4)
Patients' satisfaction with care
1, 3 months
Healthcare resource utilization
3, 6 months
Differeces in End of Life (EoL) care aggressiveness criteria
3, 6 months
Caregivers' satisfaction with care
1, 3 months
Study Arms (2)
Structured interventions tailored to PROMs cut-off
EXPERIMENTAL• Experimental group, which will follow a structured palliative care pathway (specific intervention defined in the protocol) based on the frailties identified at baseline PROMs (defined by cut-off).
Classic Palliative Car interventions
ACTIVE COMPARATOR• Control group, which will undergo standard unstructured palliative care (based on PROMs as usual, but without cut-off or interventions' checklists)
Interventions
Symptoms/needs domains are defined according to protocol-specified cut-offs, followed by the activation of a tailored intervention based on structured checklists targeting the reported symptoms/needs.
Multidisciplinary palliative care interventions are delivered according to usual clinical practice, without activation based on predefined cut-offs or structured algorithms.
Eligibility Criteria
You may qualify if:
- diagnosis of advanced/metastatic cancer
- age \> 18
- Eastern Cooperative Oncology Group (ECOG) performance status ≥2
- prognostic clinical prediction \>1 month.
You may not qualify if:
- Serious medical or psychiatric illness that can interfere with informed consent and participation in this clinical study
- any condition that is unstable or could jeopardize the safety of the patient and their compliance in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Augusto Caracenilead
Study Sites (1)
IRCCS Istituto Nazionale dei Tumori, Via Venezian n1
Milan, Lombardy, 20133, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 5, 2026
First Posted
March 13, 2026
Study Start
November 2, 2025
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The study protocol, statistical analysis plan, and informed consent form template will be made available upon reasonable request following study registration and may be shared prior to publication. De-identified individual participant data underlying the published results, together with a data dictionary, will be made available beginning 6 months after publication of the primary results and for at least 5 years thereafter. Data will be shared through a controlled access process, subject to submission of a methodologically sound proposal, approval by the study steering committee, and execution of a Data Access Agreement, in compliance with GDPR and GCP standards.
De-identified IPD underlying published results, together with the study protocol, statistical analysis plan, and data dictionary, will be shared in line with the FAIR principles and the "as open as possible, as closed as necessary" approach of Horizon Europe. Data management will follow a predefined Data Management Plan and comply with Regulation (EU) 2016/679 (GDPR) and GCP standards. Data will be available from 6 months after publication for at least 5 years through controlled access, subject to a scientifically sound proposal, steering committee approval, and a Data Access Agreement.